← Eichor
Study identifier: NCT06865235 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy and Safety of Gonioscopy Assisted Transluminal Trabeculotomy in Patients with Primary Open-angle Glaucoma and Cataract.

Condition: Open Angle Glaucoma (OAG)  ·  Sponsor: Faculdade de Ciências Médicas de Minas Gerais

PhaseNA
Planned participants90
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

Prospective, randomized, , double-blind, clinical trial, comparing the variation of intraocular pressure (IOP) of patients with mild or moderate primary open-angle glaucoma (OAG) and cataract divided into three groups. All study participants should be treated for the pathology with one or more hypotensive medications or, regardless of the number of drugs, when IOP is greater than 20 mmHg and less than 26 mmHg. The two-year follow-up should also compare the reduction in the number of medications used, reoperation rate, adverse effects, visual acuity, endothelial loss, induction of astigmatism, variation in IOP according to axial diameter of the eye, anterior chamber and age, in addition to the existence of change in the quality of life of patients in the postoperative period

This description comes directly from the study's public registry record.

Talk to the study team

Daniel F Moura, MD  ·  +5531991055860  ·  dfmoftalmo@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Instituto de Olhos Ciências Médicas - Faculdade de Ciências Médicas de Minas GeraisBelo Horizonte, Minas Gerais, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06865235